Works matching IS 0195668X AND DT 2020 AND VI 41 AND IP 2


Results: 22
    1
    2
    3
    4
    5
    6
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.

    Published in:
    European Heart Journal, 2020, v. 41, n. 2, p. 239, doi. 10.1093/eurheartj/ehz566
    By:
    • Jang, Hyun-Duk;
    • Lee, Sang Eun;
    • Yang, Jimin;
    • Lee, Hyun-Chae;
    • Shin, Dasom;
    • Lee, Hwan;
    • Lee, Jaewon;
    • Jin, Sooryeonhwa;
    • Kim, Soungchan;
    • Lee, Seung Ji;
    • You, Jihye;
    • Park, Hyun-Woo;
    • Nam, Ky-Youb;
    • Lee, Sang-Hak;
    • Park, Sahng Wook;
    • Kim, Jin-Soo;
    • Kim, Sang-Yeob;
    • Kwon, Yoo-Wook;
    • Kwak, Soo Heon;
    • Yang, Han-Mo
    Publication type:
    Article
    17

    2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)

    Published in:
    European Heart Journal, 2020, v. 41, n. 2, p. 255, doi. 10.1093/eurheartj/ehz486
    By:
    • Cosentino, Francesco;
    • Grant, Peter J;
    • Aboyans, Victor;
    • Bailey, Clifford J;
    • Ceriello, Antonio;
    • Delgado, Victoria;
    • Federici, Massimo;
    • Filippatos, Gerasimos;
    • Grobbee, Diederick E;
    • Hansen, Tina Birgitte;
    • Huikuri, Heikki V;
    • Johansson, Isabelle;
    • Jüni, Peter;
    • Lettino, Maddalena;
    • Marx, Nikolaus;
    • Mellbin, Linda G;
    • Östgren, Carl J;
    • Rocca, Bianca;
    • Roffi, Marco;
    • Sattar, Naveed
    Publication type:
    Article
    18
    19
    20
    21
    22

    Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.

    Published in:
    European Heart Journal, 2020, v. 41, n. 2, p. 231, doi. 10.1093/eurheartj/ehy808
    By:
    • Böhm, Michael;
    • Schumacher, Helmut;
    • Teo, Koon K;
    • Lonn, Eva M;
    • Mahfoud, Felix;
    • Ukena, Christian;
    • Mann, Johannes F E;
    • Mancia, Giuseppe;
    • Redon, Josep;
    • Schmieder, Roland E;
    • Sliwa, Karen;
    • Marx, Nikolaus;
    • Weber, Michael A;
    • Williams, Bryan;
    • Yusuf, Salim
    Publication type:
    Article